Nasal spray shows promise for COVID smell loss
NCT ID NCT05970731
First seen Mar 21, 2026 · Last updated Jun 13, 2026 · Updated 14 times
Summary
This study tested a steroid nasal spray (beclomethasone) against a placebo in 16 adults who lost their sense of smell for more than 3 months after COVID. The goal was to see if the spray could improve smell function and quality of life. The trial was small and early-stage, so results are not yet conclusive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST ACUTE SEQUELAE COVID-19 HYPOSMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.